Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.119 34 days ( 77.91 % )
Last Price $0.380 18.38 %
High/ Low $0.220 - $0.380 31.82%
Chg 7 Days 11.44 % $0.341 $0.380
Chg 30 Days -58.70 % $0.92 $0.380
Chg 12 mos 62.39 % $0.234 $0.380
Trend - 3 mos -77.71 % Width: 1,099.63 %
Trend - 12 mos 27.54 % Width: 2,154.36 %
Pred. range - 3 mos $0.0094 - $0.113 -97.52 % - -70.25 %
Pred. range - 12 mos $0.357 - $8.06 -5.96 % - 2,019.98 %
Short MA avg 3 mos Sell Apr 25, 2024 - 3 days
Long MA avg 3 mos Buy Mar 08, 2024 - 36 days
Short/Long MA avg 3 mos Sell Mar 05, 2024 - 39 days
Short MA avg 12 mos Buy Mar 08, 2024 - 36 days
Long MA avg 12 mos Buy Feb 27, 2024 - 44 days
Short/Long MA avg 12 mos Sell Dec 29, 2023 - 83 days
Pivot Short Sell Apr 19, 2024 - 7 days
Bollinger Buy Feb 28, 2024 - 43 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi... AMPE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT